Protective Role of Inhaled Steroids for Covid-19 Infection

Summary

We hypothesize that inhaled steroid therapy and long acting beta 2 adrenergic agonist, widely prescribed in asthma patients, may also have a local protective effect against coronavirus infection, even in patients without asthma. The primary purpose is To compare time to clinical improvement in patients receiving standard of care associated to the combination budesonide/formoterol or standard of care only. Time (in days) to clinical improvement is defined as the time from randomization to an improvement of two points (from the status at randomization) on a seven-category ordinal scale or live discharge from the hospital, whichever came first within 30 days.

Timeline

Start

2020-04-13

Primary completion

2021-05-28

Completion

2021-05-28

Outcome

Outcome not reported

Stopped (Enrollment): “Insufficient recruitment”

Drugs

Indications